Belén J. M.
- Country
- Spain
- Department
- Medicina interna
Research Overview
Data & Insights
Has run more than one trial at 0 of 9 partner sites.
Specializations
Solid Tumor Oncology
This investigator concentrates on therapeutic strategies for a broad spectrum of solid malignancies, including breast cancer, prostate cancer, non‑small cell lung cancer, urothelial cancer and ovarian cancer.
- Advanced breast cancer
- Metastatic prostate cancer
- Resectable non‑small cell lung cancer
- High‑risk urothelial cancer
- Advanced ovarian cancer
Emphasis is placed on targeted agents, immunotherapies and precision‑medicine approaches.
Hematologic Oncology
The clinical portfolio includes extensive work on plasma‑cell disorders, particularly multiple myeloma, across disease stages.
- Newly diagnosed multiple myeloma
- Relapsed multiple myeloma
- Maintenance therapy in multiple myeloma
- Minimal residual disease monitoring for multiple myeloma
Research focuses on novel agents and strategies to deepen and sustain response.
Viral Infectious Diseases
Investigator activities address chronic infection management, with a primary focus on human immunodeficiency virus.
- Antiretroviral regimen optimization for human immunodeficiency virus
- Long‑term virologic suppression in human immunodeficiency virus
- Safety and adherence strategies for human immunodeficiency virus therapy
The goal is to improve therapeutic durability while minimizing adverse effects.
Respiratory & Allergic Disorders
Clinical investigations encompass severe airway disease and allergy, notably severe asthma with an eosinophilic phenotype and allergic rhinoconjunctivitis to dust‑mite allergens.
- Treatment of severe asthma with eosinophilic phenotype
- Management of allergic rhinoconjunctivitis to Dermatophagoides species
- Biomarker‑guided therapy for severe asthma
- Combination biologic approaches in severe asthma
Efforts aim to integrate biologic agents and personalized dosing regimens.
Corneal & Ocular Surface Disease
Research includes innovative interventions for Fuchs endothelial corneal dystrophy, targeting visual outcomes and endothelial preservation.
- Surgical adjuncts for Fuchs endothelial corneal dystrophy
- Post‑operative visual recovery in Fuchs endothelial corneal dystrophy
- Endothelial cell protection strategies for Fuchs endothelial corneal dystrophy
The focus is on optimizing corneal health while reducing procedural complications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.